Search Results 491-500 of 10502 for cannabis
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...
A gift to save lives! ... Your Annual Fund gift can drive advancements in cancer care. Give Today.
Young KA, Rodeheffer RJ, Bird JG, Miranda WR, Chen HH, Oh JK, Kane GC. Association of Impaired Relaxation Mitral Inflow Pattern (Grade 1 Diastolic Function) ...
Collaborators. Research collaborations help advance scientific discovery. Our lab collaborates with other Mayo Clinic researchers on our main research ...
Brandon Wilbanks, Ph.D. student in Biochemistry and Molecular Biology, shares research on a new way to get therapies, such as drugs and proteins, ...
The purpose of this study is to provide wheelchair users with personal-use technology that provides effective feedback to increase movement to prevent pressure ...
Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.
This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...
View this Mayo Clinic YouTube video, including signs of whooping cough (pertussis) exhibited by a 21-month-old boy and an interview with Thomas Boyce, M.D..
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.